FDA Approves ACIPHEX Sprinkle for Use in Children

The Eisai capsules have been approved for treatment of GERD in children ages one to 11.

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved ACIPHEX Sprinkle Delayed-Release Capsules 5mg and 10mg for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks.  

No votes yet
Syndicate content